Chao Xingyuan

Title: Chao Xingyuan: Innovator in Nuclear Hormone Receptor Research

Introduction

Chao Xingyuan is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of molecular biology, particularly in the study of nuclear hormone receptors. His innovative work has led to the development of important technologies that have potential therapeutic applications.

Latest Patents

Chao Xingyuan holds a patent for "Nucleic acid molecules encoding nuclear hormone receptor coactivators and uses thereof." This patent includes isolated nucleic acid molecules encoding Thyroid Receptor-Associated Proteins (TRAPS). TRAPS are integral components of protein complexes that interact with nuclear hormone receptors in a ligand-dependent manner. Upon activation by corresponding hormones, these receptors regulate the transcription of specific genes. The patent also outlines methods for replicating and expressing these isolated nucleic acid molecules, as well as pharmaceutical compositions that include TRAPS. Furthermore, it describes methods for modulating gene expression through the administration of therapeutically effective amounts of these pharmaceutical compositions.

Career Highlights

Chao Xingyuan is affiliated with The Rockefeller University, where he conducts his research. His work has garnered attention for its potential impact on understanding gene regulation and developing new therapeutic strategies.

Collaborations

Chao has collaborated with notable scientists in his field, including Robert G. Roeder and Joseph D. Fondell. These collaborations have further enriched his research and contributed to advancements in molecular biology.

Conclusion

Chao Xingyuan is a distinguished inventor whose work in nuclear hormone receptor research has led to valuable patents and collaborations. His contributions continue to influence the field and hold promise for future therapeutic developments.